No diabetic ketoacidosis (DKA) events occurred [10]
These mechanisms occur within hours after GCs administration and may lead to hyperglycemia, even in individuals without a prior history of glucose abnormalities ( Figure 1 The clinical impact of hyperglycemia during GCs therapy has been well established, with multiple studies reporting increased morbidity and mortality, including higher rates of infection, cardiovascular events and prolonged hospitalisations ( Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are not currently recommended in SID by major guidelines, their mechanism of action makes them promising candidates to counteract the metabolic impacts of steroids
TrimRx ensures that clients begin immediately so they see progress quickly
Eat bland, low-fat, and less greasy/oily foods
As opposed to this study, we did not find a difference between tirzepatide 10 mg and semaglutide 2.0 mg in terms of HbA 1c or body weight reduction
Related posts Comments are closed.
